At a glance

Thymulin Quick Reference

Community research dose: Members only
Sign in to view dosing details.
Reported route: SubQ injection
Community convention, not an approved route
Cycle: Members only
Sign in to view dosing details.
Research focus: Zinc-dependent thymic signaling
Immune physiology; treatment benefit unproven

Overview

What Is Thymulin?

Thymulin is a naturally occurring peptide secreted by thymic epithelial cells. Its nine-amino-acid sequence is pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn. The peptide component is also called serum thymic factor, or FTS; binding zinc produces the biologically active complex, FTS-Zn.

That zinc dependence is central to the story. Thymulin participates in T-cell differentiation and immune signaling, and human zinc-depletion experiments found reduced thymulin activity that recovered after zinc repletion. Those findings describe the body’s own hormone activity, rather than proving that injecting a research vial improves immunity. Human zinc-deficiency study.

Thymulin is different from Thymalin, a thymic peptide preparation, and Vilon, a synthetic dipeptide. Their sequences, formulations, and research cannot be used interchangeably. Topical zinc-thymulin has also been explored for hair loss, but that route has a separate, preliminary evidence base.

Mechanism

Thymulin Mechanism of Action

Zinc-Dependent Structure

Zinc binding stabilizes the active peptide conformation. Structural work characterized the zinc–nonapeptide complex, rather than treating zinc as an optional supplement. Structural study.

T-Cell Signaling

Thymulin has been studied as a mediator of T-cell differentiation. In human zinc depletion, lower thymulin activity accompanied changes in lymphocyte subsets and IL-2 activity; zinc repletion reversed several measures. Human experiment.

Thymic Secretion

Experiments with human thymic epithelial cells found that zinc influenced thymulin secretion. This supports a relationship between nutrient status and thymic hormone activity. Cell and animal study.

Inflammatory Response

Anti-inflammatory effects are reported in experimental disease models. A mouse study reported reduced inflammatory cytokine responses. This does not establish infection prevention or treatment in people. Inflammation study.

Research findings

Thymulin Benefits

The most useful findings concern thymulin biology and zinc status. Evidence for administering thymulin as a treatment is much less developed.

Evidence: human physiology, experimental models, and preliminary topical research

Immune Signaling

Its relationship to T-cell differentiation makes thymulin relevant to thymic function research. This does not demonstrate fewer infections from injectable use.

Zinc-Status Research

Human depletion and repletion experiments show that thymulin activity responds to zinc availability, even when routine plasma zinc measures do not clearly reveal mild deficiency.

Inflammation Models

Experimental work explores inflammatory regulation in several tissues. Human symptom relief, effective dose, and duration remain unresolved.

Topical Hair Research

A small uncontrolled zinc-thymulin study explored androgenetic alopecia. Its preliminary findings need controlled replication and do not support extrapolating to injections. Topical pilot study.

Protocol planning

Thymulin Dosing Protocol

Members Access Only

Sign in or create a free account to view this content.

Preparation

Thymulin Reconstitution

Reconstitution Example

10mg vial + 2mL BAC water

Result5mg/mL

Reconstitution steps

1

Prepare

Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.

2

Add diluent slowly

Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.

3

Dissolve gently

Swirl or roll the vial until the contents dissolve; do not shake.

4

Storage

Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal.

N=1 reports

Thymulin Community Experience

Self-reported anecdotal experiences aggregated from public & private peptide community discussions and anonymous peptideprotocols.app user reports. This information does not carry the same weight as published research.

Areas of Interest

Immune research. Interest centers on thymic signaling and T-cell function.
Healthy-aging discussion. Thymic changes with age motivate research, but rejuvenation claims exceed the clinical evidence.
Hair research. Topical zinc-thymulin attracts separate interest following an early pilot study.

Interpretation Limits

Name confusion. Thymulin, Thymalin, and other thymic peptides are frequently conflated.
Product differences. Zinc-bound and uncomplexed materials may not behave alike.
Attribution. Illness patterns, zinc status, and simultaneous compounds complicate self-reported outcomes.

Stacking & synergy

Thymulin Stacking & Synergy

No controlled human evidence establishes these combinations. These comparisons explain overlapping research interests rather than proven synergy.

Thymulin + Thymosin Alpha-1

Both involve immune signaling, but they are distinct peptides with different evidence. Overlapping immune activity is a reason to study interactions, not assume additive benefits.

Thymulin + Vilon

A thymic research comparison: zinc-dependent nonapeptide signaling versus a synthetic KE dipeptide. Combining them would make it harder to isolate either contribution.

Thymulin + GHK-Cu

Topical hair and skin research is the overlap. Zinc-thymulin and copper-peptide findings do not establish compatibility in one formulation or benefit from combining them.

Safety notes

Thymulin Side Effects & Safety

Human physiology studies do not establish the safety of an injected research product. Adverse-event frequency, interactions, and long-term effects remain poorly characterized.

Thymulin’s immune activity and zinc-dependent formulation require compound-specific evaluation; safety cannot be borrowed from another thymic peptide.

Potential Route-Related Effects

Injected products can cause local redness, pain, or irritation.
Hypersensitivity may involve the peptide or formulation ingredients.
Topical tolerability findings apply to the tested topical formulation.

Important Unknowns

No established long-term injectable safety profile.
No reliable human interaction map for immune therapies or peptide stacks.
Product identity, zinc content, and contamination vary independently of purity claims.

Thymulin Precautions

Avoid or Discuss With a Clinician If

Pregnant, breastfeeding, or under 18; relevant safety data are lacking.
Known hypersensitivity to the peptide or formulation.
Autoimmune disease, transplant history, active cancer, or a significant immune disorder.

Use caution with

Immunosuppressive medicines and other immune-modulating therapies.
Unsupervised zinc supplementation: excess zinc can disturb copper balance. NIH zinc information.

Research status: The cited studies do not establish an approved injectable protocol. A research-use-only label does not establish clinical safety.

Final verdict

Peptide Protocols Verdict on Thymulin

Not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.

Our opinionated opinion

What catches our attention is the zinc connection. Thymulin has a real physiological story behind it, and the human zinc-depletion work is more informative than a vague “immune support” claim. We think the peptide deserves a place in the library for that reason.

Where we pull back is the leap from biology to a retail injection protocol. We do not have personal Thymulin experience to report, and we would not borrow a dose from Thymalin, Vilon, or a topical hair formula simply because the names or goals overlap.

For us, this is a research-first C: interesting enough to follow, with formulation details and better human intervention data needed before we could be more enthusiastic about practical use.